This suggests that MBD2 may ultimately contribute to DNA hypomethylation and aberrant gene expression in peripheral T cells of patients with autoimmune diseases by modulating DNA methylation levels and patterns, and inhibiting gene transcription (Table 1). The gene discussed is MBD2; the disease is autoimmune disease.